Biospecimen & Consent Management

BioFortis, a Q2 Solutions Company

Patient samples are the lifeblood of your clinical trials. Our unique software solution tracks these samples through their lifecycle across the ecosystem of sites, labs, biorepositories, and other trial partners.

Clinical Samples Have Complex Logistics & Lifecycle

With the increase in importance of patient samples and consent, there is also a dramatic increase in complexity. This complexity stems from the number and variety of sample-based tests, “live” decision-making during the conduct of trials based on sample test results, and the globally distributed nature of the outsourced organizations that handle patient samples. As a result, researchers are facing a number of new challenges.

Clinical Trial Sample & Consent Tracking (CTST)

Follow the patient, follow the sample: Patient samples are the lifeblood of your biomarker-driven clinical trials. Our unique software solution tracks these samples through their lifecycle across the ecosystem of sites, labs, biorepositories, and other trial partners.  

Your study teams are empowered with up-to-date, accurate and actionable insights on biospecimen and related patient informed consent activities, boosting trial execution productivity while reducing operational and compliance risks for both ongoing trials and future translational medicine studies.

Next Generation Biobanking

A biobank is a liability, not an asset – unless it can provide significant value for scientific research. Laboratory Information Management Systems (LIMS) have traditionally treats biobanking as a stand-alone activity, but we see the biobank as just one component in an integrated translational and clinical research ecosystem.

This requires an IT solution that seamlessly supports data integration, data management, and advanced search capabilities, in addition to operational biobanking workflows. With Next Generation Biobanking, you can reap the benefits of a well-annotated patient and sample database that supports precision medicine, clinical trials, translational research, and patient registries.

Data Exploration, Supercharged

Navigating the path to precision medicine is quickly becoming a "big data" problem, necessitating the harmonization of disparate healthcare, biomarker, clinical research, and real world evidence data sets.

The ability to integrate, standardize, and turn the various sets of “big data” into “smart data” is key to producing scientific insights. Our patented Qiagram technology empowers scientific minds in hypothesis generation and evaluation by allowing researchers to easily ask sophisticated ad hoc questions about complex data sets via an intuitive visual interface.

Outsourced Biospecimen Management Services

Supplement your biospecimen management team with our employees, or outsource the entire biospecimen lifecyle management process to us. In conjunction with Labmatrix™ and Qiagram, the world class biospecmen and consent lifecycle management tools from BioFortis, we can manage issue identification and resolution, root cause analyses, and continuous improvement on your behalf.

Sample Consent Codification & Management Services

The implementation of electronic consent in clinical trials continues to evolve. Our consent codification and management services provide the resources and capabilities to digitize and codify consent

Learn more about how our biospecimen & consent management solutions meet customer needs.
Next Generation Biobanking

Learn about the BioFortis solution for the critical challenges faced by precision medicine biobanks

Using Labmatrix™ at a Big Biopharma Company to Reduce Clinical Trial Delays, Costs and Regulatory Risks

Qiagram: Generating Scientific Insights through Deep Collaboration

Clinical Trial Biospecimen and Consent Tracking

Learn about the BioFortis solution for addressing new challenges around sample and consent tracking

Read More